Earnings History Data for Spero Therapeutics, Inc. (SPRO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Spero Therapeutics, Inc.

Spero Therapeutics Inc. is a multi-asset, clinical-stage biopharmaceutical company. It focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections. Spero Therapeutics Inc. is based in CAMBRIDGE, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
13-03-2024	AH		SPRO	Spero Therapeutics, Inc.	92.22	0.96	-0.17	0.55	Spero Therapeutics GAAP EPS of $0.96 beats by $1.06, revenue of $73.5M beats by $54.87M [3/13/2024 4:18 PM]	1.75	0.09 (5.12%)	1.82	0.16 (9.64%)	0.99 - 2.00	2,292,723	220,000	2,142,612
Spero Therapeutics GAAP EPS of $0.96 beats by $1.06, revenue of $73.5M beats by $54.87M [3/13/2024 4:18 PM]
13-11-2023	AH		SPRO	Spero Therapeutics, Inc.	55.33	0.02	-0.15	-0.33	Spero Therapeutics GAAP EPS of -$0.06 misses by $0.03, revenue of $25.5M beats by $10.53M [11/13/2023 4:19 PM]	1.07	-0.04 (-3.60%)	1.16	0.05 (4.50%)	0.99 - 2.12	332,458	140,000	241,802
Spero Therapeutics GAAP EPS of -$0.06 misses by $0.03, revenue of $25.5M beats by $10.53M [11/13/2023 4:19 PM]
10-08-2023	AH		SPRO	Spero Therapeutics, Inc.	77.81	-0.23	-0.28	-0.87	Spero Therapeutics GAAP EPS of -$0.23 beats by $0.11, revenue of $2.72M beats by $1.64M [8/10/2023 4:19 PM]	1.41	-0.04 (-3.10%)	1.47	0.02 (1.38%)	0.71 - 3.18	431,279	500,000	17,396
Spero Therapeutics GAAP EPS of -$0.23 beats by $0.11, revenue of $2.72M beats by $1.64M [8/10/2023 4:19 PM]
11-05-2023	AH	4:05 PM ET (May 11)	SPRO	Spero Therapeutics, Inc.	101.99	-0.25	-0.34	-1.01	Spero Therapeutics GAAP EPS of -$0.25 beats by $0.08, revenue of $2.07M beats by $0.8M [5/11/2023 4:17 PM]	1.85	-0.07 (-3.65%)	1.90	-0.02 (-1.04%)	0.68 - 3.18	553,932	340,000	7,511
Spero Therapeutics GAAP EPS of -$0.25 beats by $0.08, revenue of $2.07M beats by $0.8M [5/11/2023 4:17 PM]
30-03-2023	AH	4:05 PM ET (Mar 30)	SPRO	Spero Therapeutics, Inc.	83.36	0.55	-0.40	-0.90	Spero Therapeutics GAAP EPS of $0.55 beats by $0.51, revenue of $47.44M beats by $24.57M [3/30/2023 4:30 PM]	1.45	0.01 (0.69%)	1.57	0.13 (9.03%)	0.68 - 8.79	4,815,448	550,000	2,648,256
Spero Therapeutics GAAP EPS of $0.55 beats by $0.51, revenue of $47.44M beats by $24.57M [3/30/2023 4:30 PM]
14-11-2022	AH	4:05 PM ET (Nov 14)	SPRO	Spero Therapeutics, Inc.	68.38	-0.33	-0.34	-0.70	Spero Therapeutics GAAP EPS of -$0.33 misses by $0.03, revenue of $2M misses by $3.42M [11/14/2022 4:21 PM]	1.88	-0.15 (-7.39%)	1.93	-0.10 (-4.85%)	0.68 - 17.08	867,367	1,110,000	55,983
Spero Therapeutics GAAP EPS of -$0.33 misses by $0.03, revenue of $2M misses by $3.42M [11/14/2022 4:21 PM] Spero Therapeutics Announces Third Quarter 2022 Operating Results and Provides Business Update [Nov-14-22 04:05PM] Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Misses Revenue Estimates [Nov-14-22 05:25PM]
10-08-2022	AH	4:05 PM ET (Aug 10)	SPRO	Spero Therapeutics, Inc.	24.72	-0.87	-0.88	-0.63	Spero Therapeutics GAAP EPS of -$0.87, revenue of $1.99M [8/10/2022 4:50 PM]	0.7761	-0.07 (-8.69%)	0.82	-0.03 (-3.88%)	0.68 - 19.87	412,759	270,000	9,603
Spero Therapeutics GAAP EPS of -$0.87, revenue of $1.99M [8/10/2022 4:50 PM] Spero Therapeutics Announces Second Quarter 2022 Operating Results and Provides Business Update [Aug-10-22 04:05PM] Spero Therapeutics to Provide Business Update and Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022 [Aug-09-22 08:05AM]
16-05-2022	AH	4:05 PM ET (May 16)	SPRO	Spero Therapeutics, Inc.	55.68	-1.01	-0.87	-0.66	Spero Therapeutics GAAP EPS of -$1.01 misses by $0.08, revenue of $2.07M beats by $0.14M [5/16/2022 4:09 PM]	1.64	-0.07 (-3.94%)	1.58	-0.13 (-7.60%)	1.50 - 19.87	549,006	2,800,000	2,495
Spero Therapeutics GAAP EPS of -$1.01 misses by $0.08, revenue of $2.07M beats by $0.14M [5/16/2022 4:09 PM] Spero Therapeutics Announces First Quarter 2022 Operating Results and Provides Business Update [May-16-22 04:05PM] Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Lags Revenue Estimates [May-16-22 05:35PM]
31-03-2022	AH	4:05 PM ET (Mar 31)	SPRO	Spero Therapeutics, Inc.	254.39	-0.90	-0.80	-0.68	Spero Therapeutics GAAP EPS of -$0.90 misses by $0.15, revenue of $2.74M misses by $2.21M [3/31/2022 4:17 PM]	7.12	-1.58 (-18.16%)	6.98	-1.72 (-19.77%)	6.57 - 19.87	890,229	260,000	21,568
Spero Therapeutics GAAP EPS of -$0.90 misses by $0.15, revenue of $2.74M misses by $2.21M [3/31/2022 4:17 PM] Spero Therapeutics slips after FDA feedback on antibacterial therapy [4/1/2022 8:29 AM] Spero Therapeutics Announces Fourth Quarter and Full Year 2021 Operating Results and Provides Business Update [Mar-31-22 04:05PM] Spero Therapeutics, Inc. (SPRO) Reports Q4 Loss, Lags Revenue Estimates [Mar-31-22 05:55PM]
10-11-2021	AH	4:00 PM ET (Nov 10)	SPRO	Spero Therapeutics, Inc.	563.21	-0.70	-0.74	-0.86	Spero Therapeutics EPS misses by $0.04, misses on revenue [11/10/2021 4:27 PM]	16.92	-0.10 (-0.59%)	17.02	0.0 (0.00%)	11.75 - 23.64	55,159	100,000	1,347
Spero Therapeutics EPS misses by $0.04, misses on revenue [11/10/2021 4:27 PM] Spero Therapeutics Announces Third Quarter 2021 Operating Results and Provides Business Update [Nov-10-21 04:05PM] Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Tops Revenue Estimates [Nov-10-21 05:45PM]
05-08-2021	AH	4:00 PM ET (Aug 5)	SPRO	Spero Therapeutics, Inc.	444.22	-0.63	-0.77	-0.85	Spero Therapeutics EPS beats by $0.12, beats on revenue [8/5/2021 4:52 PM]	14.14	-0.04 (-0.28%)	14.14	-0.04 (-0.27%)	8.50 - 23.64	91,779	80,000	1,080
Spero Therapeutics Announces Second Quarter 2021 Operating Results and Provides Business Update [Aug-05-21 04:01PM] Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Tops Revenue Estimates [Aug-05-21 05:55PM]
06-05-2021	AH	4:05 PM ET (May 6)	SPRO	Spero Therapeutics, Inc.	406.27	-0.66	-0.61	-1.22	Spero Therapeutics EPS misses by $0.01, beats on revenue [5/6/2021 4:55 PM]	13.42	0.67 (5.25%)	13.42	0.0 (0.00%)	8.50 - 23.64	101,670	110,000	2,743
Spero Therapeutics EPS misses by $0.01, beats on revenue [5/6/2021 4:55 PM] Spero Therapeutics, Inc. to Host Earnings Call [May-06-21 02:30PM] Spero Therapeutics Announces First Quarter 2021 Operating Results and Provides Business Update [May-06-21 04:01PM] Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Tops Revenue Estimates [May-06-21 06:05PM]
11-03-2021	AH	4:05 PM ET (Mar 11)	SPRO	Spero Therapeutics, Inc.	441.00	-0.68	-0.79	0.00	Spero Therapeutics EPS beats by $0.06, misses on revenue [3/11/2021 4:21 PM]	16.87	-1.05 (-5.86%)	17.65	-0.27 (-1.51%)	5.25 - 23.64	179,182	159,655	1,444
Spero Therapeutics EPS beats by $0.06, misses on revenue [3/11/2021 4:21 PM] Spero Therapeutics, Inc. to Host Earnings Call [Mar-11-21 02:30PM] Spero Therapeutics Announces Fourth Quarter and Full-Year 2020 Operating Results and Provides Business Update [Mar-11-21 04:07PM] Spero Therapeutics, Inc. (SPRO) Reports Q4 Loss, Lags Revenue Estimates [Mar-11-21 05:45PM]
05-11-2020	AH	4:05 PM ET (Nov 5)	SPRO	Spero Therapeutics, Inc.	367.48	-0.86	-0.91	-0.95	Spero Therapeutics EPS beats by $0.03, beats on revenue [11/5/2020 4:37 PM]	13.65	-0.24 (-1.73%)	14.50	0.63 (4.54%)	5.25 - 14.94	213,496	193,675	300

06-08-2020	AH	4:05 PM ET (Aug 6)	SPRO	Spero Therapeutics, Inc.	256.82	-0.85	-1.17	-0.74	Spero Therapeutics EPS beats by $0.28, misses on revenue [8/6/2020 4:33 PM]	13.51	0.82 (6.44%)	13.60	0.47 (3.58%)	5.25 - 14.48	59,952	119,809	2,430